CytomX Therapeutics Inc. (NASDAQ: CTMX)
$1.0700
-0.0200 ( +0.94% ) 1.2M
CytomX Therapeutics Inc is an oncology-focused biopharmaceutical company that is operating in the United States. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.
Market Data
Open
$1.0700
Previous close
$1.0900
Volume
1.2M
Market cap
$83.74M
Day range
$1.0560 - $1.0950
52 week range
$0.8330 - $5.8500
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Mar 21, 2024 |
4 | Insider transactions | 1 | Mar 21, 2024 |
4 | Insider transactions | 1 | Mar 21, 2024 |
10-k | Annual reports | 100 | Mar 11, 2024 |
8-k | 8K-related | 13 | Mar 11, 2024 |
4 | Insider transactions | 1 | Jan 19, 2024 |
4 | Insider transactions | 1 | Jan 19, 2024 |
4 | Insider transactions | 1 | Jan 19, 2024 |
4 | Insider transactions | 1 | Jan 19, 2024 |
4 | Insider transactions | 1 | Jan 19, 2024 |